BioCardia Inc (BCDA)

BioCardia (BCDA) Stock Price & Analysis


BCDA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.23 - $2.60
Previous Close$1.77
Average Volume (3M)28.96K
Market Cap
Enterprise Value$32.49M
Total Cash (Recent Filing)$4.86M
Total Debt (Recent Filing)$1.55M
Price to Earnings (P/E)-2.7
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.65
Shares Outstanding20,219,087
10 Day Avg. Volume70,533
30 Day Avg. Volume28,962
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)-1.33
Price to Sales (P/S)587.62
Price to Cash Flow (P/CF)-3.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue23.96
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.92
Price Target Upside402.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was BioCardia Inc’s price range in the past 12 months?
BioCardia Inc lowest stock price was $1.23 and its highest was $2.60 in the past 12 months.
    What is BioCardia Inc’s market cap?
    Currently, no data Available
    When is BioCardia Inc’s upcoming earnings report date?
    BioCardia Inc’s upcoming earnings report date is Aug 10, 2023 which is in 70 days.
      How were BioCardia Inc’s earnings last quarter?
      BioCardia Inc released its earnings results on May 10, 2023. The company reported -$0.17 earnings per share for the quarter, missing the consensus estimate of -$0.16 by -$0.01.
        Is BioCardia Inc overvalued?
        According to Wall Street analysts BioCardia Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does BioCardia Inc pay dividends?
          BioCardia Inc does not currently pay dividends.
          What is BioCardia Inc’s EPS estimate?
          BioCardia Inc’s EPS estimate is -$0.15.
            How many shares outstanding does BioCardia Inc have?
            BioCardia Inc has 20,219,088 shares outstanding.
              What happened to BioCardia Inc’s price movement after its last earnings report?
              BioCardia Inc reported an EPS of -$0.17 in its last earnings report, missing expectations of -$0.16. Following the earnings report the stock price went up 0.503%.
                Which hedge fund is a major shareholder of BioCardia Inc?
                Currently, no hedge funds are holding shares in BCDA


                BioCardia Stock Smart Score

                The BioCardia stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                BioCardia Inc

                BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA.


                Top 5 ETFs holding BCDA

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold BCDA. The ETFs are listed according to market value of BCDA within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Adverum Biotechnologies
                Cidara Therapeutics
                Eledon Pharmaceuticals
                Eloxx Pharmaceuticals

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis